SCHEMBL6529447

SCHEMBL6529447

Cc1nc(C(=O)[C@@H]2C[C@H](F)CN2C(=O)OC(C)(C)C)no1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 10/20 0.51
DPP8 Q6V1X1 6/20 0.51
DPP7 Q9UHL4 6/20 0.51
GPR119 Q8TDV5 1/20 0.36
CYP1A2 P05177 1/20 0.34
POLB P06746 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C19 P33261 1/20 0.34
PTPN1 P18031 1/20 0.33
PIK3CD O00329 1/20 0.32
PIK3CA P42336 1/20 0.32
PIK3CB P42338 1/20 0.32
PIK3CG P48736 1/20 0.32
HSD11B1 P28845 1/20 0.32
UCHL1 P09936 1/20 0.32
HTRA1 Q92743 1/20 0.32
TGM2 P21980 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6529292 0.88 DPP4 (0.66) DPP4DPP8DPP7CYP1A2POLB
SCHEMBL6529428 0.88 DPP4 (0.66) DPP4DPP8DPP7CYP1A2POLB
SCHEMBL6531352 0.81 DPP4 (0.45) DPP4DPP8DPP7
SCHEMBL6528970 0.79 DPP4 (0.79) DPP4DPP8DPP7
SCHEMBL6527845 0.79 DPP4 (0.61) DPP4DPP8DPP7GPR119POLB
SCHEMBL6530127 0.79 DPP4 (0.56) DPP4DPP8DPP7GPR119CYP1A2
SCHEMBL6532393 0.74 DPP4 (0.61) DPP4DPP8DPP7CYP1A2POLB
SCHEMBL6530249 0.74 DPP4 (0.61) DPP4DPP8DPP7CYP1A2POLB
SCHEMBL1334717 0.73 NR1H2 (0.39) DPP4CYP1A2POLBCYP3A4CYP2C19
SCHEMBL641763 0.73 HSD17B10 (0.42) DPP4CYP1A2POLBCYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005037828-A1 NOVEL INHIBITORS OF DPP-IV, METHODS OF PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AS AN ACTIVE AGENT LG LIFE SCIENCES LTD. (KR) 2005-04-28 WO disclosed